Surgery: light – thermal – and electrical application – Light – thermal – and electrical application – Electrical therapeutic systems
Reexamination Certificate
2007-07-17
2007-07-17
Layno, Carl (Department: 3766)
Surgery: light, thermal, and electrical application
Light, thermal, and electrical application
Electrical therapeutic systems
C607S122000, C607S129000
Reexamination Certificate
active
10460149
ABSTRACT:
Terminating supraventricular arrhythmias through parasympathetic nerve stimulation. The method comprises detecting a supraventricular arrhythmia, stimulating a parasympathetic nerve and determining whether the supraventricular arrhythmia terminated or worsened. Various exemplary methods include delivering one or more stimulation pulses during postinspiration and/or in response to one or more cardiac events.
REFERENCES:
patent: 4712555 (1987-12-01), Thornander et al.
patent: 4788980 (1988-12-01), Mann et al.
patent: 4940052 (1990-07-01), Mann et al.
patent: 4944298 (1990-07-01), Sholder
patent: 5024222 (1991-06-01), Thacker
patent: 5193535 (1993-03-01), Bardy et al.
patent: 5199428 (1993-04-01), Obel et al.
patent: 5203326 (1993-04-01), Collins
patent: 5243980 (1993-09-01), Mehra
patent: 5330507 (1994-07-01), Schwartz
patent: 5330508 (1994-07-01), Gunderson
patent: 5334221 (1994-08-01), Bardy
patent: 5356425 (1994-10-01), Bardy et al.
patent: 5466245 (1995-11-01), Spinelli et al.
patent: 5466254 (1995-11-01), Helland
patent: 5476483 (1995-12-01), Bornzin et al.
patent: 5507784 (1996-04-01), Hill et al.
patent: 5522854 (1996-06-01), Ideker et al.
patent: 5549655 (1996-08-01), Erickson
patent: 5620468 (1997-04-01), Mongeon et al.
patent: 5700282 (1997-12-01), Zabara
patent: 5720295 (1998-02-01), Greenhut et al.
patent: 5836974 (1998-11-01), Christini et al.
patent: 5836976 (1998-11-01), Min et al.
patent: 6006134 (1999-12-01), Hill et al.
patent: 6134470 (2000-10-01), Hartlaub
patent: 6141590 (2000-10-01), Renirie et al.
patent: 6272377 (2001-08-01), Sweeney et al.
patent: 6314323 (2001-11-01), Ekwall
patent: 6449503 (2002-09-01), Hsu
patent: 6473644 (2002-10-01), Terry, Jr. et al.
patent: 6611713 (2003-08-01), Schauerte
patent: 6687540 (2004-02-01), Marcovecchio
patent: 6690971 (2004-02-01), Schauerte et al.
patent: RE38654 (2004-11-01), Hill et al.
patent: 6876880 (2005-04-01), Hess et al.
patent: 6889079 (2005-05-01), Bocek et al.
patent: 2003/0040774 (2003-02-01), Terry, Jr. et al.
patent: 2003/0078623 (2003-04-01), Weinberg et al.
patent: 2004/0230252 (2004-11-01), Kullok et al.
patent: 2005/0267542 (2005-12-01), David et al.
patent: 0 547 734 (1993-06-01), None
patent: 0 547 734 (1993-06-01), None
patent: 0 547 734 (1993-06-01), None
patent: 0 688 577 (1995-12-01), None
patent: 1 106 206 (2001-06-01), None
patent: 1 304 135 (2003-04-01), None
patent: 1 304 135 (2003-04-01), None
Mendelowitz, “Advances in Parasympathetic Control of Heart Rate and Cardiac Function,” News Physio. Sci., 1999; 14:155-161.
Pauza et al., “Morphology, Distribution, and Variability of the Epicardiac Neural Ganglionated Subplexuses in the Human Heart”, Anatomical Record, 2000; 259:353-382.
Kawada et al., “Vagosympathetic Interactions in Ischemia-Induced Myocardial Norepinephrine and Acetylcholine Release,” Am. J. Physiol Heart Circ. Physiol., 2001; 280:H216-H221.
Wen et al., “Electrophysiological Mechanisms and Determinants of Vagal Maneuvers for Termination of Paroxysmal Supraventricular Tachycardia,” Circulation, 1998; 98:2716-2723.
Olguin et al., “Heterogeneous Atrial Denervation Creates Substrate for Sustained Atrial Fibrillation,” Circulation, 1998; 98:2608-2614.
Rahme et al., “Effect of Autonomic Neurotransmitters on Excitable Gap Composition in Canine Atrial Flutter,” Cam. J. Physiol., Pharm., 2001; 79:13-17.
Ringdahl, “Vagally Mediated Atrial Fibrillation in a Young Man,” Arch Fam. Med., 2000; 9:389-390.
Schlepper, “Einflüsse des Autonomen Nervensystems bei Supraventrikulären Rhythmusstörungen,” Z. Kardiol., 1986; 75, Suppl. 5:35-40.
Burger et al., “Comparison of the Occurrence of Ventricular Arrhythmias in Patients with Acutely Decompensated Congestive Heart Failure Receiving Dobutamine Versus Nesiritide Therapy,” Am. J. Cardiol., 2001; 88:35-39.
Levett et al., “Cardiac Augmentation can be Maintained by Continuous Exposure of Intrinsic Cardiac neurons to a β-Adrenergic Agonist or Angiotensin II,” J. Surg. Research, 1996; 66:167-173.
Wallick et al., “Separate Parasympathetic Control of Heart Rate and Atrioventricular Conduction of Dogs,” Am. Phys. Society, 1990; 259(28):H536-H542.
Mazgalev et al., “Autonomic Modification of the Atrioventricular Node During Atrial Fibrillation Role in the Slowing of Ventricular Rate,” Circulation, 1999; 99:2806-2814.
Chen et al., “Intracardiac Stimulation of Human Parasympathetic Nerve Fibers Induces Negative Dromotropic Effects: Implication with the Lesions of Radiofrequency Catheter Ablation,” J. Cardiovasc. Electrophysiol., Mar. 1998; vol. 9, No. 3: 245-252.
Lazzara et al., “Selective in Situ Parasympathetic Control of the Canine Sinoatrial and Strioventricular Nodes,” Circulation Research, Mar. 1973, vol. XXXII:393-401.
Schauerte et al., “Ventricular Rate Control During Atrial Fibrillation by Cardiac Parasympathetic Nerve Stimulation: a Transvenous Approach,” J. Am. College of Cardiology, 1999; vol. 34, No. 7:2043-2050.
Waninger et al., “Characterization of Atrioventricular Nodal Response to Electrical Left Vagal Stimulation,” Annals of Biomedical Eng, 1999; vol. 27:758-762.
Kulboka et al., “Changes of Heart Electrophysiological Parameters After Destruction of Epicardial Subplexuses that Innervate Sinoatrial Node,” Medicina, 2003; 39 Tomas, No. 6: 589-595.
Cao, Ji-Min MD et al., “Relationship Between Regional Cardiac Hyperinnervation and Ventricular Arrhythmia,” CIRCULATION. 2000; 101:1960-1969.
Cohn, Jay N. MD,Preventing Congestive Heart Failure, American Family Physician, vol. 57, No. 8 (Apr. 15, 1998), pp. 1901-1904.
Du, Xiao-Jun et al., “Response to cardiac sympathetic activation in transgenic mice overexpressing β2-adrenergic receptor,” American Physiological Society (1996), pp. H630-H636.
Eisenhofer, Graeme PhD et al., “Cardiac Sympathetic Nerve Function in Congestive Heart Failure,” CIRCULATION, 1996;93:1667-1676.
Frantz, Robert P. MD, “Beta blockade in patients with congestive heart failure,” Postgraduate Medicine, vol. 108, No. 3 (Sep. 1, 2000), pp. 108-118.
Gomberg-Maitland, Mardi MD et al., “Treatment of Congestive Heart Failure,” Arch Intern Med. 2001;161:342-352.
Grassi, Guido MD et al., “Sympathetic Activation and Loss of Reflex Sympathetic Control in Mild Congestive Heart Failure,” CIRCULATION. 1995;92:3206-3211.
Kawada, Toru et al., “Vagosympathetic interactions in ischemia-induced myocardial norepinephrine and acetylcholine release,” Am J Physiol Heart Circ Physiol. 280:H216-H221, 2001.
Kirchheim, H.R. et al., “Physiology and pathophysiology of baroreceptor function and neuro-hormonal abnormalities in heart failure,” Basic Res Cardiol 93;Suppl 1, 1-22 (1998).
Kirchner, A. MD et al., “Left vagus nerve stimulation suppresses experimentally induced pain,” NEUROLOGY 2000;55:1167-1171.
Krum, H, “Sympathetic activation and the role of beta-blockers in chronic heart failure,” Aust NZ J Med 1999; 29:418-427.
Levett, J.M. MD et al. “Cardiac Augmentation Can Be Maintained by Continuous Exposure of Intrinsic Cardiac Neurons to a β-Adrenergic Agonist or Angiotensin II,”, Journal of Surgical Research 66, 167-173 (1996).
Loh, Evan MD, “Overview: Old and New Controversies in the Treatment of Advanced Congestive Heart Failure,” Journal of Cardiac Failure, vol. 7, No. 2 Supp. 1 (2001), pp. 1-7.
Mazgalev, Todor N. PhD et al., “Anatomic-Electrophysiological Correlations Concerning the Pathways for Atrioventricular Conduction,” CIRCULATION. 20019;103:2660-2667.
Mizeres, Nicholas James, “The Cardiac Plexus in Man,” The American Journal of Anatomy, vol. 112, (Jan. Mar. May 1963), pp. 141-151.
Murakami, Masahiko MD et al., “Effects of Cardiac Sympathetic Nerve Stimulation on the Left Ventricular
Layno Carl
Pacesetter Inc.
Reidel Jessica L.
LandOfFree
Parasympathetic nerve stimulation for termination of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Parasympathetic nerve stimulation for termination of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Parasympathetic nerve stimulation for termination of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3778161